Back to Search
GUY GRAYSON, M.D. P.A.
M.D. P.A.
Pediatric Hematology & Oncology Physician
NPI: 1598705030Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
J0507(TX)
Research & Publications (16)
A study of the adhesion between dental cement and dentin using a nondestructive acoustic microscopy approach.
PMID 19297016·Dent Mater·2009
8-other
Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins.
PMID 19071106·Eur J Pharmacol·2009
7-preclinical
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
PMID 18931146·J Pharmacol Exp Ther·2009
7-preclinical
Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.
PMID 18695669·Bone Marrow Transplant·2008
8-other
Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.
PMID 18438986·J Med Chem·2008
7-preclinical
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
PMID 18311894·J Med Chem·2008
7-preclinical
Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists.
PMID 18272366·Bioorg Med Chem Lett·2008
7-preclinical
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.
PMID 17994110·Br J Pharmacol·2008
7-preclinical
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists.
PMID 17482819·Bioorg Med Chem Lett·2007
7-preclinical
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
PMID 16894349·Br J Pharmacol·2006
8-other
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
PMID 16759108·J Med Chem·2006
7-preclinical
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.
PMID 16146429·Epilepsia·2005
4-observational
ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
PMID 15277581·J Pharmacol Exp Ther·2004
7-preclinical
Identification and characterization of novel antagonists of the CCR3 receptor.
PMID 12857386·J Biomol Screen·2003
7-preclinical
Four new variants of the alpha2-globin gene without clinical or hematologic effects: Hb Park Ridge [alpha9(alpha7)Asn-->Lys (alpha2)], Hb Norton [alpha72(EF1)His-->Asp (alpha2)], Hb Lombard [alpha103(G10)His-->Tyr (alpha2)], and Hb San Antonio [A113(GH2)Leu-->Arg (A2)].
PMID 12144061·Hemoglobin·2002
8-other
Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
PMID 11400647·Pediatr Hematol Oncol·2001
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1911 LUBBOCK ST, SUITE C
HARLINGEN, TX 78550 - Phone
- (866) 242-0010
Quick Facts
- NPI
- 1598705030
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile